GL1X · GenesisL1 explorer

MolNFT v1 · #139172 · protein

Human GST pi conjugated with novel inhibitor, gs-esf

5X79 · Glutathione S-transferase P: “Human GST pi conjugated with novel inhibitor, gs-esf”. X-ray diffraction, 1 ligand (GF5), 5 pockets (best druggability 0.70). MolNFT v1 #139172 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
5X79
Type
protein
Length
420 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glutathione S-transferase P
EC
2.5.1.18
UniProt
P09211
Ligands
GF5
Pockets
5 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 62% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BGlutathione S-transferase P (EC 2.5.1.18)protein21062% helix, 9% strandP09211

Ligands and binding sites

  • GF5 · (2S)-2-azanyl-5-[[(2R)-3-(2-fluorosulfonylethylsulfanyl)-1-(2-hydroxy-2-oxoethylamino)-1-oxidanylidene-propan-2-yl]amino]-5-oxidanylidene-pentanoic acid · ligand · 2 copies · chains A, B
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15580.700.7971GF5
2910.370.7517empty
3560.370.7918empty
4720.350.7616empty
5710.310.7415empty

Interfaces

1 interface between chains.

  • A–B · 1327 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 5X79 · Human GST Pi conjugated with novel inhibitor, GS-ESF · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.